$69.11
0.550.8%
At close: Aug 21, 5:00 PM EST
$68.87
-0.24-0.35%
After Hours: Aug 20, 4:17 PM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
238.54M
Fund Score
Loading...
Key Statistics
Open
$69.00
High
$69.71
52 Wk High
$70.85
AUM
238.54M
Dividend
$0.62
Ex-Div Date
Dec 19, 2024
Volume
49.74K
Market Cap
$3.11B
Mgmt Fee
0.5%
P/E Ratio
9.18
Prev. Close
$68.56
Low
$68.85
52 Wk Low
$33.59
Shares Out
3.20M
Yield
1.23%
Div. Freq
-
Avg. Volume Daily
40.77K
Beta
0.74
Avg. Expense Ratio
0.50%
P/B Ratio
3.72
Recent ALPS Medical Breakthroughs ETF News
FAQ
Q
How do I buy ALPS Medical Breakthroughs ETF (SBIO) stock?
A
You can purchase shares of ALPS Medical Breakthroughs ETF (ARCA:SBIO) through any online brokerage.
Q
Who are ALPS Medical Breakthroughs ETF (SBIO) competitors?
A
There are no as such competitors for ALPS Medical Breakthroughs ETF.
Q
What is the forecast, or price target, for ALPS Medical Breakthroughs ETF (SBIO) stock?
A
There is no analysis for ALPS Medical Breakthroughs ETF to provide a consensus price target.
Q
What is the current price for ALPS Medical Breakthroughs ETF (SBIO)?
A
The stock price for ALPS Medical Breakthroughs ETF (ARCA: SBIO) is $68.87 last updated August 20, 2026 at 4:17 PM EDT.
Q
Does ALPS Medical Breakthroughs ETF (SBIO) pay a dividend?
A
There are no upcoming dividends for ALPS Medical Breakthroughs ETF.
Q
When is ALPS Medical Breakthroughs ETF (ARCA:SBIO) reporting earnings?
A
ALPS Medical Breakthroughs ETF does not have any upcoming earnings scheduled.
Q
Is ALPS Medical Breakthroughs ETF (SBIO) going to split?
A
There is no upcoming split for ALPS Medical Breakthroughs ETF.
Key Statistics
Open
$69.00
High
$69.71
52 Wk High
$70.85
AUM
238.54M
Dividend
$0.62
Ex-Div Date
Dec 19, 2024
Volume
49.74K
Market Cap
$3.11B
Mgmt Fee
0.5%
P/E Ratio
9.18
Prev. Close
$68.56
Low
$68.85
52 Wk Low
$33.59
Shares Out
3.20M
Yield
1.23%
Div. Freq
-
Avg. Volume Daily
40.77K
Beta
0.74
Avg. Expense Ratio
0.50%
P/B Ratio
3.72
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Small Cap Growth |
| Fund Inception | Dec 30, 2014 |
| Managers | Ryan Mischke Charles Perkins |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| CRNX | Crinetics Pharmaceutic... | 4.74% |
| CGON | Cg Oncology Inc | 3.29% |
| APGE | Allogene Therapeutics ... | 4.47% |
| XENE | Xenon Pharmaceuticals ... | 3.40% |
| DNTH | Dianthus Therapeutics ... | 3.05% |
| ORKA | Oruka Therapeutics Inc... | 2.99% |
| TVTX | Travere Therapeutics I... | 2.87% |
| CA | Definium Therapeutics,... | 2.53% |
| MANE | Veradermics Inc | 2.45% |
| EWTX | Edgewise Therapeutics ... | 2.36% |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved